Markus Feldkoetter

A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport’s syndrome

Burkhard Tönshoff, Lutz T. Weber, Lars Pape et al. · Kidney International · 2020 · 140 citations · Full text

Rationale, design and objectives of ARegPKD, a European ARPKD registry study

Kathrin Ebner, Markus Feldkoetter, Gema Ariceta et al. · BMC Nephrology · 2015 · 59 citations · Full text

Risk Factors for Early Dialysis Dependency in Autosomal Recessive Polycystic Kidney Disease

Kathrin Burgmaier, Kevin Kunzmann, Gema Ariceta et al. · The Journal of Pediatrics · 2018 · 58 citations · Full text

Glomerulonephritis, Hemodialysis, Urology +12

Severe neurological outcomes after very early bilateral nephrectomies in patients with autosomal recessive polycystic kidney disease (ARPKD)

Kathrin Burgmaier, Gema Ariceta, Martin Bald et al. · Scientific Reports · 2020 · 24 citations · Full text

Anterior ischemic optic neuropathy in pediatric peritoneal dialysis: risk factors and therapy

Stephanie Dufek, Markus Feldkoetter, Enrico Vidal et al. · Pediatric Nephrology · 2014 · 22 citations

Hemodialysis, Ophthalmology, Pediatric Peritoneal Dialysis +10